Michael Carleton

6.1k citations

37 papers · 3.4k indexed · 1 hit paper · h-index 22

Impact in

Cancer Research top 1%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Genetics top 1%
- Glioma Diagnosis and Treatment

Papers in ⓘ

Immunology 16
- T-cell and B-cell Immunology 8
- Immune Cell Function and Interaction 8
- Immunotherapy and Immune Responses 5
- Immune cells in cancer 3
Cancer Research 7
- MicroRNA in disease regulation 6

Co-authors: Peter S. Linsley (10 shared papers)Michele A. Cleary (7 shared papers)David L. Wiest (11 shared papers)Janell M. Schelter (4 shared papers)Aimee L. Jackson (3 shared papers)Mariëlle C. Haks (4 shared papers)Joachim M. Baehring (2 shared papers)Ricardo Zwirtes (2 shared papers)
Journals: The Journal of Immunology (4 papers)Journal of Virology (4 papers)Journal of Clinical Oncology (3 papers)Molecular and Cellular Biology (2 papers)Immunity (2 papers)
Partner nations: United States Spain Italy

In The Last Decade

Michael Carleton

36 papers receiving 3.4k citations

Hit Papers

align trajectories log scale

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma 2020 · 946 citations

Peers

Countries citing papers authored by Michael Carleton

Since Specialization

Citations

This map shows the geographic impact of Michael Carleton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Carleton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Carleton more than expected).

Fields of papers citing papers by Michael Carleton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Carleton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Carleton. The network helps show where Michael Carleton may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael Carleton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael Carleton Line = papers co-authored together Michael Carleton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma JAMA Oncology ·David A. Reardon, Alba A. Brandes, Antonio Omuro, Paul Mulholland, Michael Lim, Antje Wick, Joachim M. Baehring, Manmeet S. Ahluwalia, Patrick Roth, Oliver Bähr, Surasak Phuphanich, Juan Manuel Sepúlveda-Sánchez, Paul de Souza, Solmaz Sahebjam, Michael Carleton, Kay Tatsuoka, Corina Taitt, Ricardo Zwirtes, John H. Sampson, Michael Weller Hit paper breakdown →	2020	946
2	Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression Molecular and Cellular Biology ·Peter S. Linsley, Janell M. Schelter, Julja Burchard, Miho Kibukawa, Melissa M. Martin, Steven R. Bartz, Jason M. Johnson, Jordan M. Cummins, Christopher K. Raymond, Hongyue Dai, Nelson Chau, Michele A. Cleary, Aimee L. Jackson, Michael Carleton, Lee P. Lim	2007	450
3	Coordinated Regulation of Cell Cycle Transcripts by p53-Inducible microRNAs, miR-192 and miR-215 Cancer Research ·Sara A. Georges, Matthew C. Biery, Soo‐Yeon Kim, Janell M. Schelter, Jane Guo, Aaron N. Chang, Aimee L. Jackson, Michael Carleton, Peter S. Linsley, Michele A. Cleary, B. Nelson Chau	2008	286
4	MicroRNAs and Cell Cycle Regulation Cell Cycle ·Michael Carleton, Michele A. Cleary, Peter S. Linsley	2007	285
5	MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT Cell Cycle ·Zhan Zhang, Hong Sun, Hongyue Dai, Ryan Walsh, Maki Imakura, Janell M. Schelter, Julja Burchard, Xudong Dai, Aaron N. Chang, Robert L. Diaz, Joseph R. Marszalek, Steven R. Bartz, Michael Carleton, Michele A. Cleary, Peter S. Linsley, Carla Grandori	2009	236
6	Attenuation of γδTCR Signaling Efficiently Diverts Thymocytes to the αβ Lineage Immunity ·Mariëlle C. Haks, Juliette M. Lefebvre, Jens Peter H. Lauritsen, Michael Carleton, Michele Rhodes, Toru Miyazaki, Dietmar J. Kappes, David L. Wiest	2005	192
7	Individual-specific variation of gene expression in peripheral blood leukocytes Genomics ·Jerald P. Radich, Mao Mao, S. Stepaniants, Matthew C. Biery, John C. Castle, Terry Ward, Greg Schimmack, Sumire Kobayashi, Michael Carleton, Johanna W. Lampe, Peter S. Linsley	2004	106
8	RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure Molecular and Cellular Biology ·Michael Carleton, Mao Mao, Matthew C. Biery, Paul Warrener, Sammy Kim, Carolyn A. Buser, C. Gary Marshall, Christine Fernandes, James Annis, Peter S. Linsley	2006	100
9	Branching out to gain control: how the pre-TCR is linked to multiple functions Immunology Today ·Ada M. Kruisbeek, Mariëlle C. Haks, Michael Carleton, David L. Wiest, Alison M. Michie, Juan Carlos Zúñiga‐Pflücker	2000	99
10	Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration Cancer Chemotherapy and Pharmacology ·Nianhang Chen, Carrie Baker Brachmann, Xiping Liu, Daniel W. Pierce, Joyoti Dey, William Kerwin, Yan Li, Simon Zhou, Shihe Hou, Michael Carleton, Richard A. Klinghoffer, Maria Palmisano, Rajesh Chopra	2015	89
11	Early Growth Response Transcription Factors Are Required for Development of CD4−CD8− Thymocytes to the CD4+CD8+ Stage The Journal of Immunology ·Michael Carleton, Mariëlle C. Haks, Sigrid A. A. Smeele, Allan R. Jones, Stanley M. Belkowski, Marc A. Berger, Peter S. Linsley, Ada M. Kruisbeek, David L. Wiest	2002	80
12	Glycogen synthesis is a required component of the nitrogen stress response in Synechococcus elongatus PCC 7942 Algal Research ·Jason W. Hickman, Kimberly M. Kotovic, Cameron Miller, Paul Warrener, Brett K. Kaiser, Tracey Jurista, Mark W. Budde, Fred Cross, James M. Roberts, Michael Carleton	2013	61
13	Fatty Aldehydes in Cyanobacteria Are a Metabolically Flexible Precursor for a Diversity of Biofuel Products PLoS ONE ·Brett K. Kaiser, Michael Carleton, Jason W. Hickman, Cameron Miller, David Lawson, Mark W. Budde, Paul Warrener, Angel Paredes, Srinivas Mullapudi, Patricia Navarro, Fred Cross, James M. Roberts	2013	53
14	Role of glycoprotein PE2 in formation and maturation of the Sindbis virus spike Journal of Virology ·Michael Carleton, Hyun O. Lee, Matthew A. Mulvey, Dennis T. Brown	1997	53
15	Signals transduced by CD3epsilon, but not by surface pre-TCR complexes, are able to induce maturation of an early thymic lymphoma in vitro. PubMed ·Michael Carleton, Norman R. Ruetsch, Marc A. Berger, Michele Rhodes, Steven Kaptik, David L. Wiest	1999	53
16	Signals Transduced by CD3ε, But Not by Surface Pre-TCR Complexes, Are Able to Induce Maturation of an Early Thymic Lymphoma In Vitro The Journal of Immunology ·Michael Carleton, Norman R. Ruetsch, Marc A. Berger, Michele Rhodes, Steven Kaptik, David L. Wiest	1999	49
17	Enforced Expression of Spi-B Reverses T Lineage Commitment and Blocks β-Selection The Journal of Immunology ·Juliette M. Lefebvre, Mariëlle C. Haks, Michael Carleton, Michele Rhodes, Gomathinayagam Sinnathamby, M. Celeste Simon, Laurence C. Eisenlohr, Lee Ann Garrett‐Sinha, David L. Wiest	2005	47
18	Control of early thymocyte development by the pre-T cell receptor complex: A receptor without a ligand? Seminars in Immunology ·David L. Wiest, Michael Carleton	1999	36
19	Constitutive Notch signalling promotes CD4-CD8- thymocyte differentiation in the absence of the pre-TCR complex, by mimicking pre-TCR signals International Immunology ·Alison M. Michie, A C Chan, Maria Ciofani, Michael Carleton, J Lefèbvre, Yiping He, David Allman, David L. Wiest, (unknown), David J. Izon	2007	28
20	Developmental Arrest of T Cells in Rpl22-Deficient Mice Is Dependent upon Multiple p53 Effectors The Journal of Immunology ·Jason Stadanlick, Zhiqiang Zhang, Sang-Yun Lee, Mike Hemann, Matthew C. Biery, Michael Carleton, Gerard P. Zambetti, Stephen J. Anderson, Tamás Oravecz, David L. Wiest	2011	28

About Michael Carleton

Michael Carleton is a scholar working on Immunology, Cancer Research, Genetics, Oncology and Molecular Biology, having authored 37 papers that have together received 3.4k indexed citations. Recurring topics across this work include T-cell and B-cell Immunology (8 papers), Immune Cell Function and Interaction (8 papers), MicroRNA in disease regulation (6 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Glioma Diagnosis and Treatment (4 papers), Immune cells in cancer (3 papers) and Bacteriophages and microbial interactions (3 papers). The work is most often cited by research in Cancer Research (1.3k citations), Genetics (690 citations), Immunology (1.0k citations), Oncology (817 citations) and Molecular Biology (1.8k citations). Michael Carleton has collaborated with scholars based in United States, Spain and Italy. Frequent co-authors include Peter S. Linsley, Michele A. Cleary, David L. Wiest, Janell M. Schelter, Aimee L. Jackson, Mariëlle C. Haks, Joachim M. Baehring, Ricardo Zwirtes, Alba A. Brandes and David A. Reardon. Their work appears in journals such as The Journal of Immunology, Journal of Virology, Journal of Clinical Oncology, Molecular and Cellular Biology and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact